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NC-ND license (http://creativecommoBackground: To examine bone mineral density in extremely low birth weight infants at
discharge and investigate whether serial measurements of serum alkaline phosphatase (ALP)
and phosphate can predict bone mineralization.
Methods: The individuals were 70 preterm infants. Serum calcium, phosphate, and ALP were
measuredatweekly intervals duringadmission inextremely lowbirthweight infants (meangestational
age, 25.3 2.1 weeks; birth weight, 812.8 141.1 g). Bone mineral apparent density (BMAD) of the
lumbar spine was prospectively evaluated by dual energy X-ray absorptiometry at discharge (nZ 70).
Results: BMADwas classified as poor (< 25th percentile) at< 0.014 g/cm3, fair (25the75th percen-
tile) at< 0.014e0.021 g/cm3, and good (> 75th percentile) at> 0.021 g/cm3, based on the distri-
bution of BMAD values in infants with noncomplicated courses of prematurity (nZ 43). In a
furthermultivariate analysis, the number of total parenteral nutrition days, phosphate at 2 post-
natal weeks and 3 postnatal weeks, and ALP at 4 postnatal weeks and 5 postnatal weeks had an
impact on bone mineral density at the lumbar spine, independent of gestational age and body
weight. Peak ALP activities exceeding 650 IU/L revealed low bonemineral densitywith 80% sensi-
tivity and 64% specificity (AUC, 0.70; pZ 0.005).
Conclusion: Serial measurements of serum ALP and phosphate are associated with decreased
bone mineralization by dual energy X-ray absorptiometry at discharge in extremely low birth
weight infants.of Pediatrics, Hanyang University Seoul Hospital, 17 Haengdang-dong, Seongdong-gu, Seoul 133-792,
il.net (H.J. Lee).
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4.0/).1. Introduction
Osteopenia of prematurity involves a deficit of bone min-
eral density as a complication of premature infants born
before 32 weeks of gestational age. Decreased bone
mineralization is caused by calcium and phosphate accre-
tion and inadequate supply.1,2 After introduction of a high
mineral-containing maternal diet in the late 1980s, the
prevalence of osteopenia of prematurity decreased to 30%
or lower.1 Although radiologically detectable abnormalities
on wrist X-ray can occur at 6e8 weeks of age in preterm
neonates with overt rickets and fractures, bone mineral
density must decrease by 30e50% to be detected by this
method. Dual energy X-ray absorptiometry (DEXA) is the
gold standard in whole-body mineral measurement, and
normative data are available.3 Although it is precise and
accurate for detecting and predicting metabolic bone dis-
ease (MBD), the rationale for using a DEXA routinely in
preterm infants has not been fully established due to
bedside unavailability in neonatal care units.
By contrast, the threshold of alkaline phosphatase (ALP)
has been used as an alternative measure to identify and
guide treatment for MBD when ALP is assessed periodically.
Backstro¨m et al4 reported that peak ALP> 900 IU/L was 88%
sensitive and 71% specific for subsequent low bone density
determined by DEXA at a 3-month corrected age. Figueras-
Aloy et al5 suggested that combined values of ALP> 500 IU/
L and low bone mineral density< 0.068 g/cm2 at discharge
predicted the development of MBD for prematurity. There
are conflicting data about serial measurements of serum
ALP as a marker of early prediction of MBD in preterm in-
fants. There are few studies on the association between
serum ALP and bone mineral density with photon absorp-
tiometry in extremely low birth weight infants. We aimed
to evaluate bone mineral density in extremely low birth
weight infants at discharge and determined whether serial
measurements of ALP and phosphate predicted the risk of
decreased bone mineral density.
2. Methods
2.1. Study population
A total of 85 infants with a birth weight< 1000 g, who were
admitted to the Neonatal Intensive Care Unit of Hanyang
University College of Medicine, Seoul, Korea and discharged
alive between 2010 and 2013, were included in this study.
Of these, 70 infants completed the intervention period
prospectively and underwent a DEXA scan at term. This
study was approved by the Institutional Review Board for
human participants at the University of Hanyang. We
excluded individuals with major congenital abnormalities.
For nutritional care, fortified human milk (including 82 mge J, et al., Bone Mineral Density
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5.005calcium and 45 mg phosphorus/100 mL) or a mineral-
fortified preterm formula (including 115 mg calcium and
62 mg phosphorus/100 mL) was used. Trophic feedings were
initiated 1e3 days after birth and increased by 10e20 mL/
kg/d. Feeding volume, advancement, and fortification
were determined by neonatologists based on the same
protocol. During parenteral nutrition, calcium, phosphate,
and multivitamins with trace minerals were added as
appropriate. A supplement of 400 IU/d of vitamin D was
given to all infants. The goals for daily enteral nutrition
were 120 kcal/kg/d at tolerating enteral feeding. The in-
fants were averaging over 100e120 kcal/kg/d when they
reached full-feeding. According to the protocol of the
neonatal intensive care unit, stimulation of physical activ-
ity was provided by specially trained physiotherapists as
soon as infants were stable enough for early developmental
care. The physical activity consisted of compression and
flexion/extension for range-of-motion exercises against
passive resistance to upper and lower extremities. The
physical activity programs provided systematic holding,
massage, and tactile stimulation.
2.2. BMD measurement
Bone mineralization was assessed by total body densitom-
etry using a commercially available DEXA (Hologic QDR-
4500; Hologic, Waltham, MA, USA) in infant whole-body
mode (QDR software for Windows XP, version 12.7; Holo-
gic), with an exam performed at discharge. The exam was
carried out by a technician who had no knowledge of the
research data. Analysis was automatic and was performed
by densitometer software. The device was calibrated daily,
and the coefficient of variation remained below 2%. The
patients were placed in a prone position, with lower and
upper limbs extended. To secure the infants in position,
they were taken to the exam after being fed, and a cotton
blanket was wrapped around them from the waist down. All
scans were performed without sedation. Occasionally, the
scanning procedure was interrupted if a movement artifact
was noted, and a repeat scan was performed when the
infant had been pacified. The patient was positioned at the
midline of the table, with the top of the head 5 cm from the
edge of the table. DEXA evaluated bone mass of total body
and of the lumbar spine (L2eL4), lean mass (g), and fat
mass (g). BMD (mg/cm2) was obtained by dividing BMC (g)
by the projected bone area (cm2). In order to eliminate the
substantial effect of body weight and bone size on BMD, the
volumetric bone mineral apparent density (BMAD) of the
lumbar spine was estimated by dividing the BMD by the
square root of the projected bone area in the particular
DEXA scan.6 Reference BMAD values were obtained from 45
clinically stable preterm infants, due to the lack of
appropriate reference data for normal spinal BMD values in
premature infants. The “clinically stable” preterm infantsAccording to Dual Energy X-ray Absorptiometry is Associated with
t Infants at Discharge, Pediatrics and Neonatology (2016), http://
Table 1 Demographic, perinatal, and neonatal charac-
teristics of the study infants (nZ 70).
Characteristic Value
Gestational age (wk) 25.98 2.11
Birth weight (g) 812.8 141.18
SGA 13 (17.6)
Birth length (cm) 32.99 2.58
Birth head circumference (cm) 23.95 2.63
Male gender 44 (62.9)
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+ MODELwere defined as those who had received ventilator assis-
tance for < 28 days, tolerated full enteral nutrition before
the age of 4 weeks, received no regular diuretic or corti-
sone treatment, and did not have septic shock or necro-
tizing enterocolitis (NEC). Based on the distribution of
BMAD values of clinically stable preterm infants, we defined
the 25th percentile and 75th percentile BMD values. The
study infants were classified into the poor BMD group with
< 25th percentile of BMAD (nZ 26), the fair BMD group with
25the75th percentile of BMAD (nZ 26), or the good BMD
group with > 75th percentile of BMAD (nZ 18).
Data on gestational age, birth weight, sex, type of de-
livery, Apgar score at 1 minute and 5 minutes, preeclamp-
sia, antenatal steroid use, and histologic chorioamnionitis
were retrieved for each infant. To evaluate the effect of
the course of prematurity on BMAD, we evaluated respira-
tory distress syndrome, patent ductus arteriosus, NEC (
Grade 2), sepsis, bronchopulmonary dysplasia (BPD, 
moderate), parenteral nutrition associated cholestasis
(defined as direct bilirubin > 2.0 mg/dL), retinopathy of
prematurity, and intraventricular hemorrhage ( Grade 2).
The diagnosis of BPD was based on the need for supple-
mentary oxygen at 28 days of age. The severity of BPD was
determined at 36 weeks of gestational age; infants
breathing air had mild BPD, those who needed < 30% sup-
plementary oxygen had moderate BPD, and those needing
> 30% supplementary oxygen and/or continuous positive
airway pressure or a ventilator had severe BPD.7 Intraven-
tricular hemorrhage was defined according to Volpe.8 NEC
was defined according to Bell et al.9 Chorioamnionitis was
defined by histologic chorioamnionitis or umbilical cord
vasculitis of Grade 2 or greater, according to the grading
system suggested by Salafia et al.10 We analyzed associa-
tions between supplementary oxygen days, ventilator sup-
port, hospital days, total parenteral nutrition (TPN) days,
type of infant formula, and therapy with diuretics and
postnatal steroids. All infants had serum total ALP, calcium,
and phosphate levels reported at weekly intervals during
admission. The lowest serum calcium, lowest serum phos-
phate, and peak ALP concentrations were recorded.Cesarean section 43 (61.4)
Apgar score at 1 min 1.62 0.95
Apgar score at 5 min 3.55 1.37
Maternal age (y) 34.04 21.53
Oligohydramnios 4 (5.7)
Preeclampsia 9 (12.9)
Antenatal steroid 48 (68.6)
Histological chorioamnionitis 43 (61.4)
RDS 64 (92.8)
PDA 53 (75.7)
NEC ( Grade 2) 12 (17.1)
Culture-proven sepsis 14 (20.0)
BPD ( moderate) 31 (44.3)
PNAC 17 (24.3)
ROP 23 (32.9)
IVH ( Grade 2) 15 (21.4)
Data are presented as mean standard deviation or n (%).
BPDZ bronchopulmonary dysplasia; IVHZ intraventricular
hemorrhage; NECZ necrotizing enterocolitis; PDAZ patent
ductus arteriosus; PNACZ parenteral nutrition-associated
cholestasis; RDSZ respiratory distress syndrome; ROPZ retin-
opathy of prematurity; SGAZ small for gestational age.2.3. Statistical analysis
The sample size for this study was estimated based on the
earlier study,5 which described the outcome of ALP in very
good BMD category (> 75th percentile), with a power of 80%
(aZ 0.05, dZ 25 IU/L, pooled standard deviation (SD) Z
77 IU/L, nZ 25 in infants per group). Statistics were calcu-
lated with the Student t test and Chi-square test for means
and frequencies. Numeric data are presented as mean and
standard deviation because the data were normally distrib-
uted. Calculations were performed with SPSS software
version 17.0 (SPSS Inc., Chicago, IL, USA). All p values< 0.05
were considered statistically significant. In order to deter-
mine the risk of decreased bone mineral density, we per-
formed multivariate linear regression analysis and entered
gestational age at birth, body weight at the time of mea-
surement, presence of BPD, TPN days, peak and trough
serum concentration of phosphate at 2 and 3 weeks of
postnatal age, and peak and trough serum concentration of
total ALP at 4 and 5 weeks of postnatal age into the model.Please cite this article in press as: Lee J, et al., Bone Mineral Density
Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weigh
dx.doi.org/10.1016/j.pedneo.2016.05.005Receiver operator characteristic (ROC) curves were deter-
mined to illustrate the cutoff value of serum total peak ALP
for detecting MBD of prematurity.
3. Results
The study population was comprised of 70 premature
newborns (44 boys and 26 girls) with a mean gestational age
of 25.9 2.1 weeks. Thirteen (17.6%) newborns had a birth
weight< 10th percentile. None presented with congenital
malformations or metabolic disorders. Regarding neonatal
prematurity-related diseases, 31 (44.3%) patients pre-
sented with BPD ( moderate), 12 (17.1%) patients with
NEC, 17 (24.3%) patients with parenteral nutrition associ-
ated cholestasis, and 15 (21.4%) patients with intraven-
tricular hemorrhage (Table 1).
The study infants were classified into the poor BMD group
(< 25th percentile) with< 0.014 g/cm3 of BMAD, the fair BMD
group (25the75th percentile) with 0.014e0.021 g/cm3 of
BMAD, or the good BMD group (> 75th percentile) with
> 0.021 g/cm3 of BMAD. This classification was based on the
distribution of BMAD values of infants with noncomplicated
courses of prematurity (nZ 43). Table 2 shows DEXA data in
the three study groups. The BMD and BMAD at the lumbar
spine (L2eL4) in the poor BMD group were statistically and
significantly lower than those in the fair and good BMD groups
(p< 0.001 and p< 0.001, respectively). However, measure-
ments of weight, height, postmentrual age (PMA), andAccording to Dual Energy X-ray Absorptiometry is Associated with
t Infants at Discharge, Pediatrics and Neonatology (2016), http://
Table 2 Dual energy X-ray absorptiometry (DEXA) data in the study group.
Poor BMAD (nZ 26) Fair BMAD (nZ 26) Good BMAD (nZ 18) p
BMC (mg) 30.875 8.220 45.267 38.124 40.599 22.089 0.144
BMD (mg/cm2) 0.105 0.017 0.124 0.038 0.128 0.377 0.043
BMCs (mg) 3.128 1.084 3.796 1.604 3.625 1.374 0.200
BMDs (mg/cm2) 0.087 0.012 0.108 0.012 0.120 0.019 < 0.001
BMADs (mg) 0.014 0.001 0.019 0.003 0.023 0.003 < 0.001
Fat mass (%) 11.67 3.87 15.08 5.17 12.14 6.03 0.057
Wt at densitometry 2.42 0.46 2.40 0.42 2.35 0.45 0.885
Ht at densitometry 43.94 3.11 43.94 2.56 43.77 2.98 0.978
Hc at densitometry 31.96 1.85 31.70 1.45 31.77 1.92 0.853
PMA at densitometry 38.15 2.58 37.80 3.0 37.88 2.92 0.902
PNA at densitometry 85.46 24.31 84.50 16.24 81.33 24.77 0.819
Data are presented as mean standard deviation or n (%).
BMADsZ volumetric bone mineral apparent density; BMCZ bone mineral content; BMCsZ bone mineral content at lumbar spine;
BMDZ bone mineral density; BMDsZ bone mineral density at lumbar spine; HcZ head circumference; HtZ height; PMAZ post-
menstrual age; PNAZ postnatal age; Wt Z weight.
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among the groups. The deleterious factors influencing BMD
value are shown in Table 3. The BMD values in study groups at
discharge showed a statistically significant correlation with
BPD (pZ 0.035), TPN days (pZ 0.04), and peak ALP
(pZ 0.007). However, there were no statistically significant
correlations between BMD value and gestational age, birth
weight, or birth length. No statistically significant differ-
ences were found between BMD value and type of milk or
therapywith diuretics and postnatal steroids.We did not find
any significant difference in mean serum phosphate
(pZ 0.575), peak serumcalcium (pZ 0.339), ormean serum
ALP (pZ 0.325) through densitometry. When calcium,
phosphate, and ALP were consecutively measured from
Week 2 toWeek 7 in Figure 1 according to BMAD groups, serial
calcium levels among BMAD groups were not statistically
significant. Only Week 2 and Week 3 phosphate and Week 4
and Week 5 ALP were statistically significant among BMAD
groups. Thus, Week 2 and Week 3 phosphate and Week 4 and
Week 5 ALP were entered into the model of multivariate
logistic regression analysis for further evaluation. The poor
BMD group showed significantly lower levels of phosphate
from 2 (pZ 0.005) weeks to 3 (pZ 0.007) weeks of postnatal
age and higher levels of alkaline phosphate from 4
(pZ 0.004) weeks to 5 (p< 0.001) weeks of postnatal age
compared to the good BMD group. Serum ALP at 5 weeks was
significantly higher in the poor BMD group (676.1 187.8)
than in the fair (491.9 172.2, p< 0.001) and good BMD
groups (392.5 112.1, p< 0.001).
In a further multivariate analysis, we defined decreased
bone mineral density in prematurity as follows. The cutoff
level for desirable apparent bonemineral density in preterm
infants was obtained from the value corresponding to 25th
percentile of BMAD. This value was a BMAD of 0.014 g/cm3 at
the lumbar spine at term age. Regression analysis showed
that TPN days, phosphate at 2 postnatal weeks and 3 post-
natal weeks, and ALP at 4 postnatal weeks and 5 postnatal
weeks had an impact on BMD at the lumbar spine, indepen-
dent of gestational age and body weight (Table 4).
The diagnostic performance of peak total ALP activity in
detecting low BMAD at discharge is illustrated in the ROC
curves (Figure 2). Peak ALP activities exceeding 650 IU/LPlease cite this article in press as: Lee J, et al., Bone Mineral Density
Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weigh
dx.doi.org/10.1016/j.pedneo.2016.05.005revealed low bone mineral density with 80% sensitivity and
64% specificity (pZ 0.005). The area under theROCcurvewas
70% for peakALP for thediagnosis of lowbonemineral density.4. Discussion
This study demonstrated that prolonged low phosphate at 2
postnatal weeks and 3 postnatal weeks and high ALP at 4
postnatal weeks and 5 postnatal weeks were correlated
with decreased bone mineral density by DEXA at discharge
in extremely low birth weight infants. ALP has been sug-
gested as an alternative measure for early screening and
aggressive mineral supplementation for MBD. However, the
correlation between serum ALP and bone mineral density
detected by DEXA remained questionable. There are con-
flicting data regarding the association between serum ALP
and bone mineral density with photon absorptiometry in
extremely low birth weight infants.11 Clinical symptoms of
osteopenia based on the radiological findings of rickets are
related to morbidity in the form of fractures.12 Although
DEXA can accurately detect and monitor MBD, it is not
routinely feasible in clinically unstable preterm infants who
are at risk for rickets.13 A growing body of evidence sug-
gests that elevated ALP is a clinically useful marker for
predicting the risk of osteopenia and rickets, based on ra-
diographs at term-equivalent age.14 However, there are
still no standard cutoff levels for MBD screening with DEXA
in extremely low birth weight infants.15
In comparison with previous studies, the poor BMD values
were determined as less than the 25th percentile (< 16 mg/
cm3) of volumetric bone mineral density to estimate appro-
priate reference data in our findings. Furthermore, clinically
stable preterm infants were first sorted by the course of
prematurity to adjust for the effect of disease in this study. In
particular, this study was performed to assess low mineral
density as measured by DEXA at term-equivalent age,
combining neonatal serial ALP measurements in a prospec-
tive design. In our study, a peak ALP level of 650 IU/L was
similar to that observed in previous studies. Hung et al16
demonstrated that a total ALP> 700 IU/L at 3 weeks of
postnatal age led to 73% sensitivity and 74% specificity for theAccording to Dual Energy X-ray Absorptiometry is Associated with
t Infants at Discharge, Pediatrics and Neonatology (2016), http://
Table 3 Risk factors influencing bone mineral density in the study group.
Poor BMAD (nZ 26) Fair BMAD (nZ 26) Good BMAD (nZ 18) p
Gestational age (wk) 26.30 2.01 25.74 2.45 25.88 1.69 0.612
Birth weight (g) 795.38 160.28 828.51 110.26 814.70 158.59 0.699
SGA 6 (23.1) 3 (11.5) 4 (22.2) 0.507
Male gender 16 (61.5) 15(57.7) 13 (72.2) 0.609
Antenatal steroid 21 (80.8) 15 (57.7) 12 (66.7) 0.354
RDS 24 (92.3) 24 (92.3) 16 (94.1) 0.969
PDA 18 (65.2) 22 (84.6) 13 (72.2) 0.400
Ligation 12 (46.2) 14 (53.8) 7 (38.9) 0.615
NEC ( Grade 2) 5 (19.2) 3 (11.5) 4 (22.2) 0.612
Culture-proven sepsis 6 (23.1) 5 (19.2) 3 (16.7) 0.866
BPDmoderate 16 (61.5) 11 (42.3) 4 (22.2) 0.035
PNAC 7 (26.9) 7 (26.9) 3 (16.7) 0.682
ROP ( Stage 2) 8 (30.8) 11 (42.3) 4 (22.2) 0.363
IVH ( Grade 2) 8 (30.8) 3 (11.5) 4 (22.2) 0.239
Furosemide 10 (38.5) 10 (38.5) 3 (16.7) 0.237
Oxygen days 76.96 28.74 68.07 26.40 66.61 41.59 0.481
Ventilator days 28.34 20.41 23.03 16.45 22.38 15.53 0.451
Hospital days 94.64 26.92 92.57 16.57 99.55 36.17 0.689
TPN days 41.61 18.03 36.30 12.24 29.77 13.21 0.040
Diuretic use (d) 10 (38.5) 10 (38.5) 3 (16.7) 0.237
Breast milk with/without formula 25 (96.2) 24 (92.3) 16 (88.9) 0.649
Exclusively fortified breast milk 5 (19.2) 8 (30.8) 5 (27.8) 0.410
Dexamethasone use 10 (38.5) 11 (42.3) 8 (44.8) 0.918
Lowest Ca (mg/dL) 6.97 1.05 6.83 1.08 7.33 0.98 0.294
Lowest P (mg/dL) 2.25 0.65 2.71 1.20 2.73 0.72 0.118
Peak ALP (IL/L) 747.42 200.11 674.38 237.24 539.83 160.39 0.007
Serum P at densitometry 9.74 0.43 9.59 0.54 9.48 0.78 0.575
Serum Ca at densitometry 6.23 0.81 6.08 0.50 5.99 0.92 0.339
Serum ALP at densitometry 386.53 140.07 341.30 99.89 344.22 106.49 0.325
Data are presented as mean SD or n (%).
ALPZ alkaline phosphatase; BMADZ bone mineral apparent density; BPDZ bronchopulmonary dysplasia; IVHZ intraventricular hem-
orrhage; NECZ necrotizing enterocolitis; PDAZ patent ductus arteriosus; PNACZ parenteral nutrition-associated cholestasis;
RDSZ respiratorydistress syndrome;ROPZ retinopathyofprematurity; SGAZ small for gestational age;TPNZ total parenteral nutrition.
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defined osteopenia as positive radiographic findings in pre-
term infants that had a gestational age 34weeks. Figueras-
Aloy et al5 identified a cutoff point of ALP> 500 IU/L for MBD
in patients with body weight (BW)< 1500 g. However, their
study assumed an ALP level of 500 IU/L as the cutoff point for
defining osteopenia, while our study quantified decreased
mineral density based on the 25th percentile and 75th
percentile BMAD distribution in preterm infants. The refer-
ence BMD values were determined in patients with a serum
ALP level< 500 IU/L. Mitchell et al14 suggested that 25% (16/
63) of infants with BW< 800 g showed radiologic rickets
despite nutritional support, but no single ALP value was
related to the radiological findings of rickets. Birth weight
was theonly factor triggering suspicion of rickets, rather than
biochemical markers, in patients with BW< 600 g. However,
their study only assessed the development of MBD based on
radiographic evaluation, while our study quantified
decreased bone mineral density by DEXA in extremely low
birth weight infants.
Our results contradict a previously published finding in
which there was no significant difference in bone mineral
content between a mean ALP cutoff of < 600 IU/L and
> 1200 IU/L. However, that study17 did not measure bonePlease cite this article in press as: Lee J, et al., Bone Mineral Density
Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weigh
dx.doi.org/10.1016/j.pedneo.2016.05.005mineral density, which takes bone volume into account, and
did not exclude infants who had clinically complicated dis-
ease that might influence ALP with fluctuation and bone
mineralization. BMD is calculated by dividing bone mineral
content by the projected bone image (area in cm2) and is
dependent on bone size, which might cause erroneous in-
terpretations of BMD values. In addition, a wide range of ALP
levels might not be linearly correlated with bone mineral
content. Our study revealed that prolonged elevation of ALP
at 4 weeks and 5 weeks after birth was a beneficial param-
eter in early detection of decreased BMD. These results may
be attributable to the volumetric measurement of BMAD at
the lumbar spine, which reflects BMD adjusted for differ-
ences in bone size and body weight. These findings are
consistent with those of Backstro¨m et al,4 who evaluated the
distribution of volumetric BMD according to DEXA. They
suggested that decreased bone mineral density was corre-
lated with a total ALP> 900 IU/L at a 3month corrected age,
after categorizing volumetric BMAD levels as above or below
95 g/cm3. BMAD might be assessed for complex three-
dimensional structures in the trabecular bone, regardless
of prematurity and sex-based differences.
ALP is of limited absolute value as a stand-alone pre-
dictor of MBD, given its significant fluctuations.18According to Dual Energy X-ray Absorptiometry is Associated with









Figure 1 Comparison of serial measurement of calcium (A), phosphate (B) and total alkaline phosphatase (C) from 2 weeks to 7
weeks’ postnatal age in the poor BMD (<25th percentile), fair BMD (25the75th percentile), and good BMD (>75th percentile) groups.
The poor BMD group showed significantly lower levels of phosphate from 2 to 3 weeks’ postnatal age and higher levels of alkaline
phosphate from 4 to 5 weeks’ postnatal age (all p < 0.01).
Figure 2 Receiver operator characteristic curves of peak
total alkaline phosphatase for detecting the 25% of infants with
the lowest bone mineral density.
Table 4 Multivariate logistic regression analysis of risk
factors influencing bone mineral density in the study group.
Adjusted p Adjusted odds ratio
(CI 95%)
Gestational age 0.125 1.294 (0.931e1.798)
Weight at densitometry 0.910 1.000 (0.999e1.002)
BPDmoderate 0.118 2.735 (0.774e9.658)
TPN days 0.037 1.052 (1.003e1.104)
Phosphate at 2 wk &
3 wk
0.033 0.901 (0.819e0.992)
ALP at 4 wk & 5 wk 0.013 1.000 (1.000e1.1002)
ALPZ alkaline phosphatase; BPDZ bronchopulmonary
dysplasia; CIZ confidence interval; TPNZ total parenteral
nutrition.
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regularly determined and maintained above 6 mg/dL
(2 mmol/L).19 A serum ALP increase at 4 weeks and 5 weeks
of postnatal age was followed by prolonged reduction in
serum phosphate level at 2 weeks and 3 weeks of postnatal
age in the decreased BMD group, when bone mineral densityPlease cite this article in press as: Lee J, et al., Bone Mineral Density
Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weigh
dx.doi.org/10.1016/j.pedneo.2016.05.005was classified by values corresponding to the 25th percentile
and 75th percentile. The elevation of ALP at 4 weeks and 5
weeks of postnatal age was followed by low plasma phos-
phate levels. Although both high ALP levels and low phos-
phate levels are associated with neonatal osteopenia,
consecutive changes of high ALP levels followed by low
phosphate levels may be considered as a marker for bony
turnover for ongoing bone mineralization. Even if serum
phosphate may be normal, ALP is a more reliable marker as
a phosphotransferase in reflecting bone stores than serum
phosphate level, which varies in renal handling ofAccording to Dual Energy X-ray Absorptiometry is Associated with
t Infants at Discharge, Pediatrics and Neonatology (2016), http://
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+ MODELphosphate. Backstro¨m et al4 showed that a combination of
serum ALP> 900 U/L and serum inorganic phosphate
< 1.8 mmol/L at a corrected age of 3 months was 100%
sensitive and 71% specific for reduced BMC, as measured by
DEXA. While Hung et al16 did not find that measurement of
phosphate increased their prognostic accuracy, even 3-
week-old infants in their osteopenic group had significantly
lower serum phosphate than infants who did not develop
MBD. Their infants also received standard calcium and
phosphorus supplementation.
This study determined BMD at discharge in extremely
low birth weight infants and identified factors and neonatal
morbidities that affect BMD. The possible mechanism of
decreased bone mineralization in infants with BPD not only
includes an inadequate mineral intake along with fluid re-
striction, but also the use of loop diuretics or systemic
steroids. Furthermore, parenteral nutrition is more prone
to aggravate osteopenia if calcium and phosphorus are not
adequately supplemented due to limited solubility of cal-
cium and phosphorus. Regression analysis showed that a
larger number of TPN days was a potential risk factor of
poor BMD at the lumbar spine, independent of gestational
age and body weight. Furthermore, provision of inadequate
phosphorous that is preceded by enteral intolerance and
fluid restriction in sick infants was attributable to reduced
BMD. Skeletal demineralization of prematurity is associated
with long parenteral nutrition, respiratory disease, NEC,
infection, and steroid use, as well as a mineral deficit.20e23
Furthermore, a peak value > 1200 IU/L in the neonatal
period was associated with reduced linear growth at 18
months of age in 857 infants with birth weight < 1850 g.18
One weakness of the present study was that the associa-
tion between vitamin D levels and bone mineralization
might have been neglected. Longitudinal extension of this
study and prospective multicenter studies are needed to
explore these complex interactions and to evaluate MBD
and linear restriction in later childhood.
Our study indicates that serial measurements of ALP and
phosphate may predict the risk of decreased bone mineral
density by DEXA at discharge in extremely low birth weight
infants. The results of this study provide reference values
for volumetric BMD determined by DEXA in clinically stable
preterm infants. The value of volumetric DEXA and its
correlation with ALP level for predicting the presence of
MBD or growth restriction in later childhood should be
analyzed in a large cohort.
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